药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Granisetron
Cyamemazine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Cyamemazine.
Granisetron
Dimetacrine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Dimetacrine.
Granisetron
Etifoxine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Etifoxine.
Granisetron
Hexamethonium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Hexamethonium.
Granisetron
Ifenprodil
The risk or severity of adverse effects can be increased when Vecuronium is combined with Ifenprodil.
Granisetron
Amperozide
The risk or severity of adverse effects can be increased when Vecuronium is combined with Amperozide.
Granisetron
Perospirone
The risk or severity of adverse effects can be increased when Vecuronium is combined with Perospirone.
Granisetron
Pomalidomide
The risk or severity of adverse effects can be increased when Vecuronium is combined with Pomalidomide.
Granisetron
Arbaclofen Placarbil
The risk or severity of adverse effects can be increased when Vecuronium is combined with Arbaclofen Placarbil.
Granisetron
Gabapentin enacarbil
The risk or severity of adverse effects can be increased when Vecuronium is combined with Gabapentin enacarbil.
Granisetron
Serotonin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Serotonin.
Granisetron
Lurasidone
The risk or severity of adverse effects can be increased when Vecuronium is combined with Lurasidone.
Granisetron
Tofisopam
The risk or severity of adverse effects can be increased when Vecuronium is combined with Tofisopam.
Granisetron
Cinitapride
The risk or severity of adverse effects can be increased when Vecuronium is combined with Cinitapride.
Granisetron
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when Vecuronium is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Granisetron
Sulthiame
The risk or severity of adverse effects can be increased when Vecuronium is combined with Sulthiame.
Granisetron
Wortmannin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Wortmannin.
Granisetron
Mebutamate
The risk or severity of adverse effects can be increased when Vecuronium is combined with Mebutamate.
Granisetron
Triclofos
The risk or severity of adverse effects can be increased when Vecuronium is combined with Triclofos.
Granisetron
Fospropofol
The risk or severity of adverse effects can be increased when Vecuronium is combined with Fospropofol.